Clinical Trials List
Protocol NumberMK-1045-007
Not yet recruiting
2026-04-20 - 2034-12-31
Phase II/III
Not yet recruiting2
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chien-Chin Lin Division of Others -
- CHENG-HONG TSAI Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- Wen-Chien Chou Division of General Internal Medicine
- Chieh-Lung Cheng Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- HSIN-AN HOU Division of General Internal Medicine
- Tai-Chung Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 莊覲瑄 Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
- 陳寧君 Division of Hematology & Oncology
- 王元欽 Division of Hematology & Oncology
- 詹筑伊 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
960 participants
